Search

Fisher & Paykel Healthcare Corp Ltd

Fechado

SetorImobiliário

32.41 -0.64

Visão Geral

Variação de preço das ações

24h

Atual

Mín

32.39

Máximo

32.49

Indicadores-chave

By Trading Economics

Rendimento

-37M

187M

Vendas

-316M

965M

P/E

Médio do Setor

50.844

59.807

Rendimento de Dividendos

1.33

Margem de lucro

19.353

Funcionários

7,384

EBITDA

-335M

319M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+13.63% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

1.33%

6.00%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-217M

19B

Abertura anterior

33.05

Fecho anterior

32.41

Sentimento de Notícias

By Acuity

92%

8%

173 / 188 Ranking em Real estate

Fisher & Paykel Healthcare Corp Ltd Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

25 de nov. de 2025, 21:31 UTC

Conversa de Mercado

F&P Healthcare's Share Price Jumps on Profit Guidance Upgrade -- Market Talk

29 de jun. de 2025, 22:48 UTC

Conversa de Mercado

Export Data Buoy Fisher & Paykel Healthcare Bull -- Market Talk

28 de mai. de 2025, 22:28 UTC

Conversa de Mercado

Fisher & Paykel Healthcare's Progress Attracts New Bull -- Market Talk

8 de abr. de 2025, 02:01 UTC

Conversa de Mercado

Tariff Impact on Fisher & Paykel Less Than Expected -- Market Talk

3 de fev. de 2025, 21:55 UTC

Conversa de Mercado

F&P Healthcare Could Make More in New Zealand to Counter Tariff Impact -- Market Talk

2 de fev. de 2025, 22:06 UTC

Conversa de Mercado

Fisher & Paykel Healthcare Slumps on Tariff Hit -- Market Talk

Fisher & Paykel Healthcare Corp Ltd Previsão

Preço-alvo

By TipRanks

13.63% parte superior

Previsão para 12 meses

Média 37.101 AUD  13.63%

Máximo 42.8 AUD

Mínimo 31 AUD

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Fisher & Paykel Healthcare Corp Ltd - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

8 ratings

4

Comprar

3

Manter

1

Vender

Sentimento

By Acuity

173 / 188 Ranking em Imobiliário

Sentimento de Notícias

Evidência Muito Forte de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
help-icon Live chat